MPDL3280A (anti-PD-L1) treatment leads to clinical activity in metastatic bladder cancer. - Powles, Thomas; Eder, Joseph Paul; Petrylak, Daniel P.; Fine, Gregg D.; Teng, Siew-leng; Shen, Xiaodong; Boyd, Zachary; Hegde, Priti S.; Chen, Daniel S.; Braiteh, Fadi S.; Loriot, Yohann; Cruz, Cristina; et al. (Nature, 2014)